Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Laser Patterning Technology Revolutionizes Stent Surgery for Cardiovascular Diseases

By HospiMedica International staff writers
Posted on 26 Dec 2024

As societies around the world age, the prevalence of vascular diseases among older populations is increasing, highlighting the growing need for therapeutic stents. More...

These devices, which help maintain blood flow by expanding narrowed or blocked blood vessels, are essential in treating various vascular conditions. However, traditional metal stents can lead to restenosis—re-narrowing of the artery—caused by excessive smooth muscle cell proliferation within a month after implantation. While drug-eluting stents are commonly used to address this issue, they can inhibit the re-endothelialization of blood vessels, which raises the risk of thrombosis and requires the use of anticoagulants. To overcome these challenges, research is ongoing to coat stent surfaces with bioactive molecules like proteins or nucleic acids. However, these coatings often fail to adequately promote endothelial cell proliferation. A new stent surface treatment, developed using laser patterning, has shown promise in encouraging endothelial cell growth while inhibiting smooth muscle cell dedifferentiation in blood vessels. By leveraging nanostructured patterns to control cellular responses, this approach could enhance vascular recovery, particularly when combined with chemical coatings.

A research team at Korea Institute of Science and Technology (KIST, Seoul, South Korea) has utilized nanosecond laser texturing technology to create micro- and nano-scale wrinkle patterns on nickel-titanium alloy surfaces. These wrinkle patterns prevent smooth muscle cell migration and morphological changes induced by stent-related vascular injury, thus reducing restenosis. Additionally, the patterns enhance cellular adhesion, aiding in re-endothelialization to restore the vascular lining. The team validated this technique through in vitro vascular cell studies and ex vivo angiogenesis assays using fetal animal bones. The laser-textured surfaces provided an environment conducive to endothelial cell proliferation while effectively suppressing smooth muscle cell dedifferentiation and excessive growth.

The study revealed that smooth muscle cell growth on the wrinkled surfaces was reduced by approximately 75%, while angiogenesis more than doubled, according to findings published in the international journal Bioactive Materials. This surface patterning technology holds promise not only for metal stents but also for biodegradable stents. When applied to biodegradable stents, the patterns could help prevent restenosis and promote endothelialization before the stent dissolves, potentially improving treatment outcomes and minimizing the risk of complications. The research team plans to conduct animal testing and clinical trials to further assess the long-term safety and effectiveness of this innovative laser patterning technology.

“This study demonstrates the potential of surface patterns to selectively control vascular cell responses without drugs,” said KIST’s Dr. Hojeong Jeon who led the research team. “Using widely industrialized nanosecond lasers allows for precise and rapid stent surface processing, offering significant advantages for commercialization and process efficiency.”


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Syringes
Prefilled Saline Flush Syringes
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.